Novartis shines in plant power

Novartis (NYSE: NVS) has dedicated a 1-megawatt solar array attached to its Vacaville, CA, biopharmaceutical site. The company expects to meet 20 percent of the plant's power needs from the $7 million system, whose 4100 solar panels cover five acres. Novartis has solar systems at five other sites. Article

Suggested Articles

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.

Korean CDMO Samsung Biologics is expanding and China API maker WuXi STA opened a 30,000-square-foot oligonucleotide manufacturing facility.